Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 372.63% | -67.32% | -75.68% | -88.61% | -182.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 365.61% | -71.07% | -75.92% | -88.95% | -170.36% |
| Operating Income | -365.61% | 71.07% | 75.92% | 88.95% | 170.36% |
| Income Before Tax | 101.68% | 60.76% | -50.77% | 118.03% | -1,614.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 101.68% | 60.76% | -50.77% | 118.03% | -1,614.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 101.68% | 60.76% | -50.77% | 118.03% | -1,614.75% |
| EBIT | -365.61% | 71.07% | 75.92% | 88.95% | 170.36% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 101.65% | 62.02% | -45.17% | 116.37% | -1,370.31% |
| Normalized Basic EPS | 101.65% | 61.41% | -57.64% | 120.30% | -1,371.10% |
| EPS Diluted | 101.65% | 62.02% | -45.17% | 116.37% | -1,370.31% |
| Normalized Diluted EPS | 101.65% | 61.41% | -57.64% | 120.30% | -1,371.10% |
| Average Basic Shares Outstanding | 1.62% | 3.32% | 3.84% | 10.16% | 16.59% |
| Average Diluted Shares Outstanding | 1.62% | 3.32% | 3.84% | 10.16% | 16.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |